Works matching IS 09395555 AND DT 2021 AND VI 100 AND IP 9


Results: 32
    1
    2
    3

    Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6–7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 9, p. 2363, doi. 10.1007/s00277-021-04540-w
    By:
    • Qin, Xia;
    • Zhu, Yi-Ping;
    • Luo, Cheng-Juan;
    • Zhou, Ming;
    • Huang, Ke;
    • Chen, Chun;
    • Zhang, Wei-Ping;
    • Sun, Yuan;
    • Luo, Rong-Mu;
    • Tang, Xiang-Feng;
    • Yang, Ting;
    • Song, Xian-Min;
    • Hu, Shao-Yan;
    • Sun, Zi-Min;
    • Hu, Jiong;
    • Wang, Shun-Qing;
    • Chen, Jing
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 9, p. 2375, doi. 10.1007/s00277-021-04569-x
    By:
    • Marzuttini, Francesca;
    • Mancusi, Antonella;
    • Bonato, Samanta;
    • Griselli, Mario;
    • Tricarico, Sara;
    • Casarola, Genni;
    • Paradiso, Matteo;
    • Ruggeri, Loredana;
    • Terenzi, Adelmo;
    • Merluzzi, Mara;
    • Prigitano, Anna;
    • Tortorano, Anna Maria;
    • Pitzurra, Lucia;
    • Falini, Brunangelo;
    • Carotti, Alessandra;
    • Velardi, Andrea;
    • Pierini, Antonio
    Publication type:
    Article
    12

    Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

    Published in:
    2021
    By:
    • Heinicke, Thomas;
    • Krahl, Rainer;
    • Kahl, Christoph;
    • Cross, Michael;
    • Scholl, Sebastian;
    • Wolf, Hans-Heinrich;
    • Hähling, Detlev;
    • Hegenbart, Ute;
    • Peter, Norma;
    • Schulze, Antje;
    • Florschütz, Axel;
    • Volker, Schmidt;
    • Reifenrath, Kolja;
    • Zojer, Niklas;
    • Junghanss, Christian;
    • Sayer, Herbert G.;
    • Maschmeyer, Georg;
    • Christian, Späth;
    • Hochhaus, Andreas;
    • Fischer, Thomas
    Publication type:
    journal article
    13
    14
    15
    16
    17
    18
    19

    Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 9, p. 2325, doi. 10.1007/s00277-021-04534-8
    By:
    • Davies, Faith;
    • Rifkin, Robert;
    • Costello, Caitlin;
    • Morgan, Gareth;
    • Usmani, Saad;
    • Abonour, Rafat;
    • Palumbo, Antonio;
    • Romanus, Dorothy;
    • Hajek, Roman;
    • Terpos, Evangelos;
    • Cherepanov, Dasha;
    • Stull, Dawn Marie;
    • Huang, Hui;
    • Leleu, Xavier;
    • Berdeja, Jesus;
    • Lee, Hans C.;
    • Weisel, Katja;
    • Thompson, Michael;
    • Boccadoro, Mario;
    • Zonder, Jeffrey
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 9, p. 2279, doi. 10.1007/s00277-021-04421-2
    By:
    • Vassilakopoulos, Theodoros P.;
    • Papageorgiou, Sotirios G.;
    • Angelopoulou, Maria K.;
    • Chatziioannou, Sophia;
    • Prassopoulos, Vassilios;
    • Karakatsanis, Stamatios;
    • Arapaki, Maria;
    • Mellios, Zois;
    • Sachanas, Sotirios;
    • Kalpadakis, Christina;
    • Katodritou, Eirini;
    • Leonidopoulou, Theoni;
    • Kotsianidis, Ioannis;
    • Hatzimichael, Eleftheria;
    • Kotsopoulou, Maria;
    • Dimou, Maria;
    • Variamis, Eleni;
    • Boutsis, Dimitrios;
    • Terpos, Evangelos;
    • Michali, Evridiki
    Publication type:
    Article
    26
    27
    28
    29
    31
    32